Treatment
18F-rhPSMA-7.3 clinical trials
We’re tracking 6 recruiting studies that include 18F-rhPSMA-7.3, each written for real people, not researchers, below.
Recruiting studies
- NCT05413850RecruitingPhase 1/Phase 2
Lu-177 PSMA drug study for advanced prostate cancer
This early-stage study tests a radioactive prostate cancer medicine that targets PSMA (a protein on prostate cancer cells). It aims to see how well the treatment works and how safe it is for men whose cancer has spread and shows PSMA on a scan.
Miami, FloridaAges 18 years+ - NCT06389786Recruiting
Using a new PET scan to find cancer spread before prostate surgery
This trial tests a special PET/MRI scan that may help doctors see if prostate cancer has spread to nearby lymph nodes before surgery. It could help guide treatment decisions for men with high-risk prostate cancer.
Jacksonville, FloridaAges 30–85 - NCT06617481RecruitingPhase 2
PET scan study for early prostate cancer recurrence
This trial uses a special PET scan to detect prostate cancer when your PSA level is slightly rising after prostate removal surgery. It aims to find cancer early so treatment decisions can be better informed.
Orlando, FloridaAges 18 years+ - NCT06865768RecruitingPhase 2
New PET-MRI scan for better prostate biopsy guidance
This trial tests a new imaging scan that combines a special PET tracer with MRI to help guide a prostate biopsy. The goal is to see if this scan can more accurately find cancer and reduce the need for extra biopsies.
Atlanta, GeorgiaAges 18 years+ - NCT07011342Recruiting
Testing a new PET scan after focal treatment for prostate cancer
This trial tests a new type of PET scan to see how well it finds leftover cancer after you've had focal therapy (treatment to just part of the prostate) for intermediate-risk prostate cancer in the last 9 months.
Hackensack, New JerseyAges 18 years+ - NCT07220720RecruitingPhase 2
PET scan for suspicious prostate spots before biopsy
This trial tests whether a special PET scan (called POSLUMA) can help find prostate cancer earlier in men who have an MRI showing a suspicious spot (PIRADS 2 or 3) but haven't yet had a biopsy. If you are scheduled for a biopsy, this scan may give your doctor extra information before the procedure.
Jacksonville, FloridaAges 18–100
What 18F-rhPSMA-7.3 is being studied for
Conditions with recruiting 18F-rhPSMA-7.3 studies.
Common questions
- Are there clinical trials studying 18F-rhPSMA-7.3?
- Yes. Clin2 currently lists 6 recruiting studies that include 18F-rhPSMA-7.3, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a 18F-rhPSMA-7.3 trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is 18F-rhPSMA-7.3 an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether 18F-rhPSMA-7.3 or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.